Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
G protein-coupled receptor class C group 6 member A (GPRC6A) is a member of the class C G protein-coupled receptor superfamily characterized by a seven-transmembrane domain structure and a large N-terminal extracellular domain with an amino acid-sensing motif[4][2][1]. It is activated by multiple ligands, including various L-α-amino acids, divalent cations (such as calcium and magnesium), and the bone-derived hormone osteocalcin, and functions as a membrane androgen receptor[1][2][5]. GPRC6A mediates rapid, non-genomic responses to testosterone and is implicated in the regulation of testosterone synthesis, metabolic sensing, and coordination of anabolic signals[1][2]. The receptor is associated with several physiological and pathological processes, including prostate cancer progression and hyperparathyroidism, and plays a role in cellular signaling pathways such as MAPK and mTORC1 activation[1][2][4]. Although extensively studied in animal models, human GPRC6A differs in trafficking and function, as most of the receptor is intracellularly retained rather than cell-surface localized[3][5]. No drugs are currently approved for clinical use targeting GPRC6A, and there are no widely accepted biomarkers or specific antagonists for this receptor[5].
Agonist binding (amino acids, osteocalcin, cations) leads to activation of G-protein signaling pathways (notably Gq/G11 and Gi), which can stimulate downstream signaling such as phospholipase C activation and CREB-dependent gene expression for steroidogenesis[2][5][1]. In prostate cells, mediates non-genomic androgen responses, including activation of MAPK and mTORC1 signaling pathways[1].
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on G protein-coupled receptor class C group 6 member A (GPRC6A).